Sign in
Home
Biotech Insights
Biotech News
CEO Interviews
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in / Join
About Us
Privacy Policy
Disclaimer
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Home
Biotech Insights
Biotech News
CEO Interviews
CEO Interviews
BiotechStocktrader Interview with Nader Pourhassan, CEO of Cytodyn, Inc.
CEO Interviews
BiotechStocktrader Interview with Dr. Carl Schwartz, CEO of Precision Therapeutics, (AIPT).
CEO Interviews
BriaCell Therapeutics (BCTXF) Presents Positive Efficacy Data with Lead Cancer Drug Candidate
CEO Interviews
Hemispherx Biopharma (HEB) Showing Strong Progress in Clinical Trials
CEO Interviews
Innovus Pharmaceuticals Continues Strong Revenue Growth & New Product Rollouts
BioTechStockTrader
About Biotech Stocktrader
Alernative Pharma
Biotech Insights
Biotech News
CEO Interviews
COVID-19
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises Proceeds of Over $10 Million from Exercise of...
CytoDyn Inc.
-
March 2, 2021
0
Big Pharma Dives Into CBD: Who Could Be Next?
CytoDyn Inc.
-
February 22, 2021
0
Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx™
CytoDyn Inc.
-
December 22, 2020
0
Biotech News
Home
Biotech News
Page 3
Biotech News
CytoDyn Submits its Top-line Report from its Phase 2 COVID-19 Trial...
CytoDyn Inc.
-
August 17, 2020
0
Biotech News
Algernon Announces Enrollment of First U.S. Patient in Multinational Phase 2b/3...
Algernon Pharmaceuticals Inc.
-
August 13, 2020
0
Biotech News
Cognetivity Neurosciences presents at virtual Alzheimer’s Association International Conference (AAIC) 2020
Cognetivity Neurosciences Ltd.
-
August 13, 2020
0
Biotech News
Generex Biotechnology Subsidiary Olaregen Therapeutix Announces Publication on the Use of...
Generex Biotechnology Corporation
-
August 13, 2020
0
1
2
3
4
...
22
Page 3 of 22
- Advertisement -
APPLE
Cardiol Therapeutics Appoints Worldwide Clinical Trials as CRO for the Company’s...
Generex Biotechnology Corporation
-
December 15, 2020
0
Biotech Insights
Trial designed to investigate the cardioprotective properties of CardiolRx(TM) in patients hospitalized with COVID-19 who have a prior history of, or risk factors for,...
RECENT POSTS
Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises Proceeds of Over...
Generex Biotechnology Corporation
-
March 2, 2021
Big Pharma Dives Into CBD: Who Could Be Next?
Generex Biotechnology Corporation
-
February 22, 2021
Clinical Trials Focus on COVID-19 and Acute Myocarditis
Generex Biotechnology Corporation
-
January 19, 2021
Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx™
Generex Biotechnology Corporation
-
December 22, 2020